"FDA's 2016 changes to mifepristone's approved conditions of use were supported by an exhaustive review of a record including dozens of scientific studies and decades of safe use of mifepristone by millions of women in the United States and around the world," attorneys for the Department of Justice said in their filing.
"The loss of access to mifepristone would be damaging for women and healthcare providers around the nation," the attorneys wrote.
[
add
]
[
|
|
...
]